Financial results - BELARCO PHARM S.R.L.

Financial Summary - Belarco Pharm S.r.l.
Unique identification code: 38894293
Registration number: J05/403/2018
Nace: 4646
Sales - Ron
-
Net Profit - Ron
-8.044
Employees
Open Account
Company Belarco Pharm S.r.l. with Fiscal Code 38894293 recorded a turnover of 2024 of - , with a net profit of -8.044 and having an average number of employees of - . The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Belarco Pharm S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 8.429 7.168 20.312 10.416 3.515 698 0
Total Income - EUR - - - 8.429 7.168 20.312 10.440 3.783 12.292 7.602
Total Expenses - EUR - - - 7.531 5.246 18.993 13.242 16.104 9.549 15.647
Gross Profit/Loss - EUR - - - 898 1.922 1.318 -2.802 -12.321 2.743 -8.044
Net Profit/Loss - EUR - - - 645 1.707 541 -3.115 -12.825 2.110 -8.044
Employees - - - 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Belarco Pharm S.r.l.

Rating financiar

Financial Rating -
BELARCO PHARM S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Belarco Pharm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Belarco Pharm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Belarco Pharm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Belarco Pharm S.r.l. - CUI 38894293

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 0 7.021 8.736 4.022 970 12.032 7.242
Current Assets - - - 6.394 5.967 8.840 19.254 10.317 21.149 28.565
Inventories - - - 185 72 122 1.695 209 208 244
Receivables - - - 52 215 1.261 9.655 3.265 14.805 22.325
Cash - - - 6.158 5.680 7.457 7.905 6.843 6.136 5.996
Shareholders Funds - - - 688 2.382 2.877 -301 -13.127 7.103 -5.906
Social Capital - - - 43 42 41 40 41 40 40
Debts - - - 2.644 8.712 13.311 10.196 19.440 21.117 36.781
Income in Advance - - - 3.062 3.003 4.786 15.769 7.371 7.348 7.307
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 28.565 euro in 2024 which includes Inventories of 244 euro, Receivables of 22.325 euro and cash availability of 5.996 euro.
The company's Equity was valued at -5.906 euro, while total Liabilities amounted to 36.781 euro. Equity decreased by -12.970 euro, from 7.103 euro in 2023, to -5.906 in 2024. The Debt Ratio was 96.3% in the year 2024.

Risk Reports Prices

Reviews - Belarco Pharm S.r.l.

Comments - Belarco Pharm S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.